Share the post "Natural Biocon (India) ‘s Q1 Update: Profit Grows by 100% YoY"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 264.21 % in the past year, decrease in net sales/revenue by -91.32 %.
- Profit over the Year and quarter: Significant improvement in profitability for Natural Biocon (India) Limited. Notable increase of 81.48 % in net profit Year to Year, Natural Biocon (India) Limited’s profitability increased by 66.1 % in this quarter.
- EPS over the Year and quarter: EPS increased by 0 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 0.271 Cr | Rs. 11.37 Cr | Rs. 0.987 Cr | -91.32 % | + 264.21 % |
Expenses | Rs. 0.22 Cr | Rs. 11.24 Cr | Rs. 0.89 Cr | -92.08 % | + 304.55 % |
Operating Profit | Rs. 0.05 Cr | Rs. 0.13 Cr | Rs. 0.1 Cr | -23.08 % | + 100 % |
OPM % | 18.45 % | 1.14 % | 10.13 % | + 8.99 % | -8.32 % |
Other Income | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Depreciation | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Profit before tax | Rs. 0.05 Cr | Rs. 0.13 Cr | Rs. 0.1 Cr | -23.08 % | + 100 % |
Tax % | 0 % | 55.73 % | 0 % | -55.73 % | 0 % |
Net Profit | Rs. 0.05 Cr | Rs. 0.06 Cr | Rs. 0.1 Cr | + 66.67 % | + 100 % |
EPS in Rs | Rs. 0 | Rs. 0.01 | Rs. 0.01 | + 0 % | 0 % |
Today, we’re looking at Natural Biocon (India) Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 264.21 %. However, it did see a marginal slip of -91.32 % from the previous quarter. Expenses decreased slightly by -92.08 % quarter-on-quarter, aligning with the annual rise of 304.55 %. Operating profit, while up 100 % compared to last year, faced a quarter-on-quarter dip of -23.08 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -8.32 %, but an expansion of 8.99 % sequentially. Profit before tax grew annually by 100 % but saw a reduction from the preceding quarter by -23.08 %.
with a more notable quarter-on-quarter decrease of -55.73 %. Net profit rose by 100 % year-on-year but experienced a 66.67 % expansion from the last quarter. but a quarterly rise of 0 %. In summary, Natural Biocon (India) Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 0.271 Cr | Rs. 11.37 Cr | Rs. 0.987 Cr | -91.32 % | + 264.21 % |
Expenses | Rs. 0.22 Cr | Rs. 11.24 Cr | Rs. 0.89 Cr | -92.08 % | + 304.55 % |
Operating Profit | Rs. 0.05 Cr | Rs. 0.13 Cr | Rs. 0.1 Cr | -23.08 % | + 100 % |
Net Profit | Rs. 0.05 Cr | Rs. 0.06 Cr | Rs. 0.1 Cr | + 66.67 % | + 100 % |
EPS in Rs | Rs. 0 | Rs. 0.01 | Rs. 0.01 | + 0 % | 0 % |
In reviewing Natural Biocon (India) Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 264.21 % year-on-year growth, although there was a slight dip of -91.32 % from the previous quarter. Expenses rose by 304.55 % compared to the previous year, with a decrease of -92.08 % quarter-on-quarter. Operating Profit surged by 100 % annually, and saw a -23.08 % decrease from the last quarter.
Net Profit showed yearly increase of 100 %, and experienced a 66.67 % increase from the previous quarter. however rose by 0 % compared to the last quarter. In essence, while Natural Biocon (India) Limited faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
[my_shortcode1]